Your browser doesn't support javascript.
loading
Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging.
Bogeska, Ruzhica; Mikecin, Ana-Matea; Kaschutnig, Paul; Fawaz, Malak; Büchler-Schäff, Marleen; Le, Duy; Ganuza, Miguel; Vollmer, Angelika; Paffenholz, Stella V; Asada, Noboru; Rodriguez-Correa, Esther; Frauhammer, Felix; Buettner, Florian; Ball, Melanie; Knoch, Julia; Stäble, Sina; Walter, Dagmar; Petri, Amelie; Carreño-Gonzalez, Martha J; Wagner, Vinona; Brors, Benedikt; Haas, Simon; Lipka, Daniel B; Essers, Marieke A G; Weru, Vivienn; Holland-Letz, Tim; Mallm, Jan-Philipp; Rippe, Karsten; Krämer, Stephan; Schlesner, Matthias; McKinney Freeman, Shannon; Florian, Maria Carolina; King, Katherine Y; Frenette, Paul S; Rieger, Michael A; Milsom, Michael D.
Afiliação
  • Bogeska R; Division of Experimental Hematology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany.
  • Mikecin AM; Division of Experimental Hematology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany.
  • Kaschutnig P; Division of Experimental Hematology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany; Faculty of Biosciences, University of Heidelberg, 69120 Heidelberg, Germany.
  • Fawaz M; Department of Medicine, Hematology/Oncology, Goethe University Hospital Frankfurt, 60590 Frankfurt, Germany.
  • Büchler-Schäff M; Division of Experimental Hematology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany; Faculty of Biosciences, University of Heidelberg, 69120 Heidelberg, Germany.
  • Le D; Program in Immunology, Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX 77030, USA.
  • Ganuza M; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London London EC1M 6BQ, UK.
  • Vollmer A; Institute of Molecular Medicine, Stem Cells and Aging, Aging Research Center, Ulm University, 89081 Ulm, Germany.
  • Paffenholz SV; Division of Experimental Hematology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany; Faculty of Biosciences, University of Heidelberg, 69120 Heidelberg, Germany.
  • Asada N; Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Rodriguez-Correa E; Division of Experimental Hematology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany; Faculty of Biosciences, University of Heidelberg, 69120 Heidelberg, Germany.
  • Frauhammer F; Faculty of Biosciences, University of Heidelberg, 69120 Heidelberg, Germany; Division of Applied Bioinformatics, DKFZ, 69120 Heidelberg, Germany.
  • Buettner F; Department of Medicine, Hematology/Oncology, Goethe University Hospital Frankfurt, 60590 Frankfurt, Germany; The German Cancer Consortium (DKTK), 69120 Heidelberg, Germany; Frankfurt Cancer Institute, 60590 Frankfurt, Germany.
  • Ball M; Division of Experimental Hematology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany.
  • Knoch J; Division of Experimental Hematology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany.
  • Stäble S; Division of Experimental Hematology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany; Faculty of Biosciences, University of Heidelberg, 69120 Heidelberg, Germany; Section Tra
  • Walter D; Division of Experimental Hematology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany.
  • Petri A; Division of Experimental Hematology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany.
  • Carreño-Gonzalez MJ; Division of Experimental Hematology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany; Faculty of Biosciences, University of Heidelberg, 69120 Heidelberg, Germany.
  • Wagner V; Division of Experimental Hematology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany; Faculty of Biosciences, University of Heidelberg, 69120 Heidelberg, Germany.
  • Brors B; Division of Applied Bioinformatics, DKFZ, 69120 Heidelberg, Germany.
  • Haas S; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany; The German Cancer Consortium (DKTK), 69120 Heidelberg, Germany; Division of Stem Cells and Cancer, DKFZ, 69120 Heidelberg, Germany; DKFZ-ZMBH Alliance, Heidelberg, Germany; Berlin Institute
  • Lipka DB; The German Cancer Consortium (DKTK), 69120 Heidelberg, Germany; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, DKFZ, 69120 Heidelberg, Germany; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany; Faculty of Medicine, Otto-von-Guericke Universit
  • Essers MAG; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany; DKFZ-ZMBH Alliance, Heidelberg, Germany; Division of Inflammatory Stress in Stem Cells, DKFZ, 69120 Heidelberg, Germany.
  • Weru V; Division of Biostatistics, DKFZ, 69120 Heidelberg, Germany.
  • Holland-Letz T; Division of Biostatistics, DKFZ, 69120 Heidelberg, Germany.
  • Mallm JP; Division of Chromatin Networks, DKFZ, 69120 Heidelberg, Germany.
  • Rippe K; Division of Chromatin Networks, DKFZ, 69120 Heidelberg, Germany.
  • Krämer S; Faculty of Biosciences, University of Heidelberg, 69120 Heidelberg, Germany; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, DKFZ, 69120 Heidelberg, Germany; Biomedical Informatics, Data Mining and Data Analytics, Faculty of Applied Computer Science and Medical
  • Schlesner M; Biomedical Informatics, Data Mining and Data Analytics, Faculty of Applied Computer Science and Medical Faculty, University of Augsburg, 86159 Augsburg, Germany; Bioinformatics and Omics Data Analysis, DKFZ, 69120 Heidelberg, Germany.
  • McKinney Freeman S; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Florian MC; Stem Cell Aging Group, Regenerative Medicine Program, The Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • King KY; Program in Immunology, Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX 77030, USA; Department of Pediatrics, Division of Infectious Diseases, Baylor College of Medicine, Houston, TX 77030, USA.
  • Frenette PS; Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
  • Rieger MA; Department of Medicine, Hematology/Oncology, Goethe University Hospital Frankfurt, 60590 Frankfurt, Germany; The German Cancer Consortium (DKTK), 69120 Heidelberg, Germany; Frankfurt Cancer Institute, 60590 Frankfurt, Germany; Cardio-Pulmonary Institute, 60590 Frankfurt, Germany.
  • Milsom MD; Division of Experimental Hematology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), 69120 Heidelberg, Germany; DKFZ-ZMBH Alliance, Heidelberg, Germany. Electronic address: michael.milsom@dkfz.de.
Cell Stem Cell ; 29(8): 1273-1284.e8, 2022 08 04.
Article em En | MEDLINE | ID: mdl-35858618
ABSTRACT
Hematopoietic stem cells (HSCs) mediate regeneration of the hematopoietic system following injury, such as following infection or inflammation. These challenges impair HSC function, but whether this functional impairment extends beyond the duration of inflammatory exposure is unknown. Unexpectedly, we observed an irreversible depletion of functional HSCs following challenge with inflammation or bacterial infection, with no evidence of any recovery up to 1 year afterward. HSCs from challenged mice demonstrated multiple cellular and molecular features of accelerated aging and developed clinically relevant blood and bone marrow phenotypes not normally observed in aged laboratory mice but commonly seen in elderly humans. In vivo HSC self-renewal divisions were absent or extremely rare during both challenge and recovery periods. The progressive, irreversible attrition of HSC function demonstrates that temporally discrete inflammatory events elicit a cumulative inhibitory effect on HSCs. This work positions early/mid-life inflammation as a mediator of lifelong defects in tissue maintenance and regeneration.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Hematopoéticas / Hematopoese Limite: Aged / Animals / Humans Idioma: En Revista: Cell Stem Cell Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Hematopoéticas / Hematopoese Limite: Aged / Animals / Humans Idioma: En Revista: Cell Stem Cell Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
...